Strata buys HLT-NRP for $21.5M to expand transplant platform
Strata Critical Medical, Inc. acquired Heart and Lung Transplant National Recovery Program (HLT-NRP) for $21.5 million, comprising 80% cash and 20% stock. The acquisition expands Strata's transplant clinical business line, with HLT-NRP projected to generate $10.0 million in revenue and $3.1 million in Adjusted EBITDA for the full year 2026.
*this image is generated using AI for illustrative purposes only.
Strata Critical Medical, Inc. has completed the acquisition of Heart and Lung Transplant National Recovery Program (HLT-NRP), a provider of transplant surgical recovery services in the United States, for a total transaction value of $21.5 million. This acquisition expands Strata's capabilities in the transplant sector by integrating HLT-NRP's specialized recovery services and network of experienced transplant surgeons in key markets such as Florida and California.
The deal structure comprises approximately 80% cash and 20% stock. The stock component will be released from a multi-year lockup, contingent upon the seller's continued participation in the business operations following the acquisition. The transaction was completed at a mid-single-digit multiple of Adjusted EBITDA, pre-synergy, consistent with Strata’s capital deployment strategy.
Strategic Impact and Financial Outlook
The acquisition adds significant scale to Transplant Clinical, Strata’s fastest growing business line. For the full year 2026, HLT-NRP is expected to generate revenue of approximately $10.0 million and Adjusted EBITDA of approximately $3.1 million. Management indicated that the combined growth and operational synergies are expected to quickly lower the effective purchase price and maximize returns.
Transaction Details
| Component | Percentage | Terms |
|---|---|---|
| Cash | 80% | Paid upfront |
| Stock | 20% | Subject to multi-year lockup |
The acquisition marks a strategic expansion for Strata Critical Medical, strengthening its service offerings in the transplant surgical recovery market and enhancing responsiveness to the transplant community.
How will Strata Critical Medical integrate HLT-NRP's specialized services into its existing Transplant Clinical line to accelerate growth?
What specific operational synergies does management anticipate to quickly lower the effective purchase price?
Will Strata pursue further acquisitions in the transplant sector following this strategic expansion?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
